Skip to main content
. 2018 May 24;40(2):693–703. doi: 10.3892/or.2018.6464

Figure 1.

Figure 1.

Tumorigenic potential of EpCAMhigh/CD44+ colorectal cancer cells in vivo. (A) Flow cytometric analysis of a human colorectal cancer. A small EpCAMhigh/CD44+ population was detected in the human colorectal cancer. (B) Only EpCAMhigh/CD44+ cells had tumorigenic potential in NOD/SCID mice. (C) Flow cytometric analysis of a xenograft tumor. EpCAMhigh/CD44+ cells gave rise to EpCAMpositive/CD44 cells and reconstituted the expression profiles of the primary sample. (D) H&E staining of a primary and a xenograft tumor. The histology of the xenograft tumor was the same as that of the primary tumor. (E) Serial transplantation recapitulated the histology of the primary tumors.